key: cord-0014374-ik50gcbo
authors: Darzianiazizi, Maedeh; Mehrani, Yeganeh; Chan, Lily; Mould, Robert C.; Kulkarni, Raveendra R.; Sharif, Shayan; Bridle, Byram W.; Karimi, Khalil
title: Type I Interferon α/β Receptor-Mediated Signaling Negatively Regulates Antiviral Cytokine Responses in Murine Bone-Marrow-Derived Mast Cells and Protects the Cells from Virus-Induced Cell Death
date: 2020-11-27
journal: Int J Mol Sci
DOI: 10.3390/ijms21239041
sha: b50432b1a57936efb99910ac218b3d5ab936a035
doc_id: 14374
cord_uid: ik50gcbo

Mast cells (MCs) are critical for initiating inflammatory responses to pathogens including viruses. Type I interferons (IFNs) that exert their antiviral functions by interacting with the type I IFN receptor (IFNAR) play a central role in host cellular responses to viruses. Given that virus-induced excessive toxic inflammatory responses are associated with aberrant IFNAR signaling and considering MCs are an early source of inflammatory cytokines during viral infections, we sought to determine whether IFNAR signaling plays a role in antiviral cytokine responses of MCs. IFNAR-intact, IFNAR-blocked, and IFNAR-knockout (IFNAR(−/−)) bone-marrow-derived MCs (BMMCs) were treated in vitro with a recombinant vesicular stomatitis virus (rVSVΔm51) to assess cytokine production by these cells. All groups of MCs produced the cytokines interleukin-6 and tumor necrosis factor-α in response to rVSVΔm51. However, production of the cytokines was lowest in IFNAR-intact cells as compared with IFNAR(−/−) or IFNAR-blocked cells at 20 h post-stimulation. Surprisingly, rVSVΔm51 was capable of infecting BMMCs, but functional IFNAR signaling was able to protect these cells from virus-induced death. This study showed that BMMCs produced pro-inflammatory cytokines in response to rVSVΔm51 and that IFNAR signaling was required to down-modulate these responses and protect the cells from dying from viral infection.

The biological role of mast cells (MCs) was initially attributed to allergic inflammation [1, 2] . However, as time passed, research findings highlighted MCs as important sentinel cells in tissues for priming and coordinating host defenses to various pathogens, including viruses [3] . Widely spread throughout the body, MCs mainly reside in tissues interfacing with the external environment, like skin, intestines, airways, and the genitourinary tract [4] [5] [6] [7] . Such strategic locations enable MCs to promptly respond to pathogens, allergens, or other intrusions. Vesicular stomatitis caused by vesicular stomatitis

To explore the potential for MCs to be infected with rVSV, BMMCs were initially either treated with medium or WT rVSV encoding a transgene for full-length enhanced green fluorescent protein (GFP) at a multiplicity of infection (MOI) of 10. The reason WT rVSV was used instead of rVSV∆m51 in these experiments was accessibility to GFP-tagged viruses. Flow cytometry data showed that a mean of 14.37% ± 1.02% (standard deviation) of c-kit + FcεRIα + BMMCs were positive for GFP expression at 10 h after exposure to the virus ( Figure 1A ). This suggested that at least some of the BMMCs could be infected with rVSV and support VSV-mediated expression of a transgene. In addition, time-lapse video microscopy of BMMCs confirmed that these cells could be infected by rVSV as demonstrated by them fluorescing green by 10 h post-treatment. BMMCs expressed GFP by six hours after adding WT rVSV-GFP to the cells. Expression of GFP peaked at 10 h and started to diminish at 12 h post-infection. No more GFP-positive cells were visible 24 h after being exposed to the virus ( Figure 1B-F) . The gradual disappearance of GFP-positive cells implied the possibility of virus-induced cell death. 

BMMCs infected with rVSV∆m51 were assessed for potential production of IL-6 and TNF-α using flow cytometry after intracellular staining. At 16 h post-infection, a mean of 16.05% ± 2.51% (standard deviation) and 15% ± 1.21% of BMMCs were positive for IL-6 and TNF-α, respectively ( Figure 2 ). To study the kinetics of virus-induced cytokine production in BMMCs, the cells were infected with rVSV∆m51 at a MOI of 10. Phorbol 12-myristate 13-acetate (PMA) and ionomycin-mediated stimulation was used as a positive control for detecting intracellular IL-6 and TNF-α. At 12 h post-infection with the virus, IL-6 and TNF-α were detectable in BMMCs (4.90% ± 0.67% and 10.4% ± 0.66%, respectively). The production of IL-6 and TNF-α increased at 16 h (16.05% ± 2.51% and 15.17% ± 1.21%, respectively), but declined at 20 h post-infection (5.87% ± 0.64% and 7.92% ± 0.88%, respectively) ( Figure 2 ). This provided a baseline cytokine profile for rVSV∆m51-treated BMMCs. Kinetics of cytokine production by murine bone-marrow-derived mast cells (BMMCs) after infection with a recombinant strain of vesicular stomatitis virus (rVSV∆m51). BMMCs were infected with rVSV∆m51 at a multiplicity of infection of 10. At 12, 16, and 20 h post-infection, the cells were stained for the surface markers FcεRIα and c-kit, as well as intracellular cytokines interleukin (IL)-6 and tumor necrosis factor (TNF)-α. The cells were then analyzed using flow cytometry. Fluorescence minus one (FMA) controls were used to set gates to identify IL-6 + and TNF-α + cells. Phorbol 12-myristate 13-acetate (PMA) and ionomycin were used as a positive control stimulus. Graphs and representative dot plots show means and standard deviations pooled from four experimental replicates of (A,B) IL-6 + and (C,D) TNF-α + FcεRIα + c-Kit + mast cells at 12, 16, and 20 h post-infection. Two-way analysis of variance with Tukey's multiple comparison test was used to define statistical significance as * p < 0.05; ** p < 0.001; **** p < 0.0001.

To investigate whether rVSV∆m51-induced cytokine responses of MCs could be influenced by the dose of virus, BMMCs were infected with rVSV∆m51 at MOIs of 0.01, 0.1, 1, 10, 1 or 100. Sixteen hours post-infection, the frequencies of IL-6-and TNF-α-positive cells correlated with the dose of the virus ( Figure 3 ). The lowest and highest frequency of IL-6 (7.16% ± 0.62% versus 66.95% ± 1.20%) and TNF-α (13.8% ± 0.78% versus 77.77% ± 1.94%) were detected in cells treated with the lowest (0.01) and highest (100) MOI of virus, respectively. The highest frequency of IL-6-and TNF-α-positive cells was starting to approach cells treated with PMA and ionomycin, with 92.85% ± 1.88% and 94.92% ± 1.46% IL-6and TNF-α-positive cells, respectively. The cells were then analyzed by flow cytometry, and fluorescence minus one (FMO) controls were used to set gates to identify IL-6 + and TNF-α + cells. Graphs and representative dot plots show means and standard deviations pooled from four experimental replicates of (A) IL-6 and (B) TNF-α expression in FcεRIα + c-Kit + mast cells after infection with rVSV∆M51 or treatment with phorbol 12-myristate 13-acetate (PMA) and ionomycin as a positive control stimulus. Two-way analysis of variance with Tukey's multiple comparison test was used to define statistical significance as ** p < 0.001; *** p < 0.0005; **** p < 0.0001.

To study the potential effect of virus-induced cytokine responses on viability of cells, equal numbers of BMMCs were treated with medium or rVSV∆m51 at a MOI of 10. After 12, 16, and 20 h, the cells were stained with a fixable viability dye so that the number of viable cells could be observed using flow cytometry. In contrast to medium-treated cells, cell viability in virus-treated cells showed a decreasing trend over the course of infection with rVSV∆m51. There was a gradual but significant reduction in the number of viable cells between 12 and 20 h post-infection as compared with controls (6572 ± 220. 52 Two-way analysis of variance with Tukey's multiple comparison test was used to define statistical significance as * p < 0.05; ** p < 0.001; *** p < 0.0005; **** p < 0.0001.

To explore the potential effect of IFNAR signaling on antiviral cytokine responses of MCs, IFNAR-intact, IFNAR-blocked, and IFNAR −/− BMMCs were treated with rVSV∆m51 at a MOI of 10 and assessed for cytokine production. PMA and ionomycin were used as control stimuli for detecting cytokines in BMMCs. All groups of cells showed an increase in production of cytokines between 12 and 16 h post-infection. However, there was a significant difference between BMMCs regarding IL-6 and TNF-α production at later time points. The frequency of BMMCs producing IL-6 and TNF-α decreased between 16 and 20 h post-infection in IFNAR-intact cells from 16.05% ± 2.51% and 15% ± 1.21% to 5.87% ± 0.64% and 7.92% ± 0.88%, respectively. In contrast, IFNAR −/− BMMCs showed a steady increase in production of both cytokines between 16-and 20 h post-infection (17.27% ± 1.61% and 25.90% ± 1.79%, respectively). Although the production of both cytokines in IFNAR-blocked BMMCs was lower than that of IFNAR −/− cells, it was still significantly higher than IFNAR-intact cells at 20 h post-infection (9.30% ± 0.79% for IL-6 and 14.75% ± 1.20% for TNF-α) ( Figure 5 ). Together, these findings highlight the importance of IFNAR signaling in the ability of BMMCs to down-regulate antiviral cytokine responses after an infection. Specifically, disruption of type I IFN signaling during a viral infection can result in over-production of cytokines by MCs.

To explore the potential effect of IFNAR signaling on virus-induced cell death, IFNAR-intact, IFNAR-blocked, and IFNAR −/− BMMCs were treated with medium or rVSV∆m51 at a MOI of 10. After 12, 16, and 20 h, the cells were stained with a fixable viability dye to look at the number of viable cells using flow cytometry. In contrast to medium-treated cells, all groups of virus-treated cells showed a reduction in cell viability after infection with rVSV∆m51 ( Figure 6A Figure 6B ). This suggested that virus-induced cytotoxicity was not dose-dependent in these cells. In contrast, the reduction in viability of IFNAR-blocked cells did correlate with the dose of the virus (2545.75 ± 520.85 cells versus 1035 ± 304.64 cells after treatment with rVSV∆M51 at MOIs of 10 and 100, respectively). . Recombinant vesicular stomatitis virus (rVSV∆m51)-induced cytokine production by murine bone-marrow-derived mast cells (BMMCs) was regulated by type I interferon receptor (IFNAR) signaling. BMMCs that were left untreated (intact BMMCs) or incubated with an antibody that blocked IFNARs (IFNAR-blocked BMMCs) or derived from IFNAR-knockout mice (IFNAR −/− BMMCs) were infected with rVSV∆m51 at a multiplicity of infection of 10. After 12, 16, and 20 h, the cells were stained for the surface markers FcεRIα and c-kit, as well as intracellular cytokines interleukin (IL)-6 and tumor necrosis factor (TNF)-α. The cells were then analyzed by flow cytometry, and fluorescence minus one (FMO) controls were used to set gates to identify IL-6 + and TNF-α + BMMCs. Expression of (A) IL-6 and (B) TNF-α expression in FcεRIα + c-Kit + mast cells is shown after infection with rVSV∆m51 or treatment with phorbol 12-myristate 13-acetate (PMA) and ionomycin as a positive control stimulus. Graphs show means and standard deviations pooled from four (IFNAR-intact and -blocked BMMCs) or six (IFNAR −/− BMMCs) experimental replicates. Two-way analysis of variance with Tukey's multiple comparison test was used to define statistical significance as ** p < 0.001; *** p < 0.0005; **** p < 0.0001. 

In the current study it was observed that the magnitude of antiviral cytokine responses of MCs was controlled by IFNAR signaling and that IFNAR signaling protected MCs from virus-induced cell death. Indeed, BMMCs produced IL-6 and TNF-α in response to rVSV∆M51, and intact IFNAR signaling was required for shutting these responses down and preventing the cells from dying.

The prevalence of MCs at common points of entry for pathogens, as well as expression of a broad array of potential entry receptors, and a wide range of inflammatory mediators have made them ideal targets for a number of viruses. In the submucosa of the respiratory tract and in the nasal cavity, viruses are sensed by MCs and release early inflammatory compounds such as histamine and proteases followed by the generation of cytokines like IL-6 [46] . It is important to note that IL-6 can play a pro-inflammatory role early in the innate response but then an anti-inflammatory role at later time points [47] . The susceptibility of MCs to viral infection varies between viruses [24] [25] [26] 28, 44, 48, 49] . However, viral infection of MCs may not necessarily lead to the release of infectious virions [24, 37, 48] . While this study shows that BMMCs could be infected with VSV, whether the infection was productive is a question that future studies may address. However, it is important to note that leukocytes have generally been thought to be resistant to infection with VSV.

In vitro, MCs have been reported to produce inflammatory cytokines and chemokines in response to different stimuli, including lipopolysaccharides [50, 51] , synthetic viral double-stranded RNA, as well as infection of viruses [20, 49] including VSV [27, 52] . In this study, in vitro-cultured BMMCs were shown to produce the cytokines IL-6 and TNF-α in response to rVSV∆M51. We could not detect significant cytokine expression by BMMCs earlier than 12 h after infection with rVSV∆M51, suggesting that the cytokines were generated as a consequence of de novo synthesis rather than being released from pre-formed pools [53] . A modest but statistically significant release of IL-6 and TNF-α in response to rVSV∆M51 was observed at 12 h post-infection, which peaked by 16 h and declined by 20 h post-infection. Moreover, we demonstrated that while IFNAR signaling does not affect the amount of TNF-α produced by BMMCs in response to rVSV∆M51 at 16 h post-infection, IL-6 generation was higher in IFNAR-intact BMMCs compared to IFNAR-blocked and IFNAR −/− BMMCs. This could be due to enhancement of IL-6 production by type I IFNs, which was previously reported in human neutrophils [54] . In such a scenario both IFNAR-blocked and IFNAR −/− BMMCs failed to respond to type I IFNs to potentiate early IL-6 production. Interestingly, at a later time point where IFNAR signaling could shut down cytokine responses in IFNAR-intact BMMCs, IFNAR-blocked and IFNAR −/− BMMCs continued to produce cytokines to toxic levels. Indeed, IFNAR signaling was required to control this cytokine production and protect the MCs from death. Relatively lower production of cytokines in IFNAR-blocked BMMCs than that of IFNAR −/− cells may imply that the antibody-mediated blockade of IFNARs might have been incomplete and that some level of IFNAR signaling was retained during infection with rVSV∆m51. If true, this would support the importance of functional IFNAR signaling in the regulation of antiviral cytokine responses.

The recombinant VSV∆m51-induced cell death in BMMCs observed in this study aligns with previous reports on attenuated strains of VSV that were found to be highly lytic in IFN-non-responsive human tumor cell lines from the NCI-60 panel (leukemia, colon carcinoma, non-small-cell lung carcinoma, melanoma, ovarian carcinoma, renal carcinoma, and prostate and breast cancer), as compared with IFN-responsive cells [55, 56] . Importantly, our findings highlight rVSV∆M51-induced cell death in primary cultures of MCs. This may be particularly relevant to oncolytic virotherapies that rely on rhabdoviruses, especially since these are versatile innate sentinel cells that can profoundly shape host immune responses to a viral infection. Infection and killing of MCs during rhabdovirus-mediated oncolytic virotherapies might be an unappreciated off-target effect especially for therapies that combine oncolytic rhabdoviruses with potent suppressors of type I interferon signaling [57] . Further, MCs might contribute to adverse events that are associated with exaggerated cytokine responses in some patients treated with oncolytic viruses. These concerns deserve thorough investigation in the future.

Moreover, influenza A virus-induced apoptosis in the P815 mouse mastocytoma cell line was associated with virus replication and production of pro-inflammatory cytokines and chemokines, including IL-6 and TNF-α. This virus-induced apoptosis was implicated in the pathogenesis of influenza A virus infections [49] . Apoptosis of MCs has also been reported to be induced by other viruses, including dengue virus [58] and rhinovirus [59] . Dengue virus-induced apoptosis in human MCs and MC lines was also associated with production of pro-inflammatory cytokines and chemokines [60] . This current study, however, did not evaluate the type of programmed cell death that in vitro-cultured MCs underwent during infection with rVSV∆m51.

Taken together, the results of this study emphasize the role of IFNAR signaling in controlling the magnitude of antiviral cytokine responses by MCs. Given that MCs are among the early cytokine-producing cells during viral infections [27] and given their well-established contributions to toxic cytokine [61] responses during severe pathogenic viral infections [62] , it is important to define the early virus-induced events that lead to unbridled inflammatory responses by these versatile cells. According to the findings of this study, it is tempting to speculate that virus-induced type I IFN responses in epithelial and mucosal cells modulate tissue-resident MCs. In the event of viral invasion associated with impaired IFNAR signaling, unrestrained inflammatory responses of MCs could lead to excessive infiltration of inflammatory cells and subsequent generation of a cytokine storm, thereby causing the development of immune-mediated pathogenesis. Further understanding of IFNAR-mediated antiviral cytokine responses of MCs might facilitate the rational development of novel strategies to prevent or treat pathogenesis associated with excessive inflammatory responses by MCs during viral infections.

Six-to 8-week-old female C57BL/6 mice were purchased from Charles River Laboratories, Senneville, QC, Canada. IFNAR −/− mice from the C57BL/6 background were kindly provided by Dr. Yonghong Wan (McMaster University, Hamilton, ON, Canada) with the permission of Dr. Laurel Lenz (University of Colorado, Denver, CO, USA) and were used as bone marrow donors for in vitro culture and development of BMMCs. All mice were kept in an isolated specific pathogen-free facility at the University of Guelph (Guelph, ON, Canada). Use of mice was approved by the University of Guelph Animal Care Committee (animal utilization protocol #3807) and adhered to the standards recommended by the Canadian Council on Animal Care.

A replication-competent WT recombinant Indiana strain of VSV carrying a transgene encoding GFP and a highly attenuated version with a deletion at position 51 of the matrix protein to remove suppression of anti-viral type I IFN responses (rVSV∆m51) [63] were kindly provided by Dr. Brian Lichty, McMaster University. These were used to study antiviral cytokine responses of BMMCs. The viruses were used in containment level 2 facilities under the approval of the University of Guelph biosafety committee (biohazard permit #A-367-04-19-05).

BMMCs were generated according to a previously described method [64] . Femurs and tibias were harvested from mice, and the marrow was flushed aseptically with Hanks' Balanced Salt Solution to give 1 × 10 5 cells/mL in tissue-culture flasks incubated at 37 • C in a 5% CO 2 humidified atmosphere. Cell culture media was refreshed once per week by centrifugation and resuspension of resulting cell pellets in fresh complete BMMC medium. It was shown previously that PWM-SCM differentiates bone-marrow-derived cells into a phenotype representative of pulmonary mast cells [65, 66] .

PWM-SCM was prepared as described [67] with minor modifications. Specifically, 2 × 10 6 splenocytes per mL of BMMC media were cultured from C57BL/6 mice and stimulated with 8 µg/mL of lectin (Sigma; cat. #L8777, Oakville, ON, Canada) for five days at 37 • C in a 5% CO 2 humidified incubator. Afterwards, the medium was collected, centrifuged for 15 min at 3005× g, and filtered through a 0.2 micron filter and archived in small aliquots in a −20 • C freezer until being used for the development of mature BMMCs.

In vitro cultured BMMCs (1 × 10 5 cells) were cytospun and stained with Wright-Giemsa for assessment of granularity via light microscopy. Purity of BMMCs was confirmed by flow cytometric analysis of the surface markers using FITC-conjugated anti-mouse CD117 (c-Kit) (clone 2B8, eBioscience; cat. #105806), APC/Cy7-conjugated anti-mouse FCεRIα (clone MAR-1, BioLegend; cat. #134326, San Diego, CA, USA), and PerCP/Cy5.5-conugated anti-mouse IL-33Rα (IL1RL1, ST2) (clone DIH9, BioLegend; cat. #145312, San Diego, CA, USA). Five-to 10-week-old BMMCs that were more than 95% double-positive for c-kit and FcεRI-α were used for experimental purposes.

Viable BMMCs were counted using 0.4% trypan blue dye (Gibco; cat. #15250, Waltham, MA, USA) exclusion, and 9 × 10 5 cells were plated in fresh complete BMMC media in a flat-bottom 96-well plate and stimulated with a range of doses of rVSV∆m51. To detect intracellular IL-6 and TNF-α, the cells were incubated with brefeldin A (1:1000) (BD Biosciences; cat. #420601, San Jose, CA, USA) 10 h before the end of the experiment to retain cytokines within the cells. Stimulation of cells with 20 ng/mL of PMA (Sigma; cat. #P1585, Oakville, ON, Canada) and 500 ng/mL of ionomycin (Sigma; cat. #I9657, Oakville, ON, Canada) was used as a positive control for detection of intracellular IL-6 and TNF-α in BMMCs. To study the role of IFNAR signaling in cytokine responses of BMMCs to rVSV∆m51, WT BMMCs were treated with 10 µg/mL of anti-mouse IFNAR-1 (clone MAR1-5A3, Leinco Technologies; cat. #0516L270, Fenton, MO, USA) two hours before stimulation with rVSV∆m51 or PMA and ionomycin. Three groups of cells were used in these experiments: WT BMMCs with intact IFNAR signaling, WT BMMCs treated with anti-IFNAR1 to block IFNAR signaling, and IFNAR −/− BMMCs without IFNAR gene expression.

Stimulated BMMCs were transferred into a U-bottom 96-well plate to be stained for surface markers and intracellular cytokines for further analysis by flow cytometry. To that end, the cells were spun down at 500× g at 4 • C for five minutes, the supernatant was removed, and cells were resuspended in flow cytometry staining buffer containing phosphate-buffered saline (Hyclone; cat. #SH0325601, Ottawa, ON, Canada) and 0. 

Viable cells were counted using an inverted light microscope and 0.4% trypan blue dye (Gibco; cat. #15250, Waltham, MA, USA) exclusion, and 1 × 10 4 cells were plated in fresh complete BMMC media containing 20% PWM-SCM in a flat-bottom 96-well plate and stimulated with a range of doses of rVSV∆m51. At the indicated time, BMMCs were stained for mast cell surface markers prior to staining with a fixable viability dye (Zombie Aqua; BioLegend, cat. #423101, San Diego, CA, USA). Ninety percent of all the cells in all samples were run through a BDCanto II flow cytometer for data acquisition. BMMCs negative for Zombie Aqua were considered as viable cells.

BMMCs were infected with WT VSV expressing a GFP transgene at a MOI of 10 in a 25 mm cell culture Petri dish, and real-time images were recorded over the course of 24 h using time-lapse microscopy (LumaScope, Bioimager). Representative images were extracted from the files that were generated.

GraphPad Prism version 8, GraphPad Software, San Diego, CA, USA was used for all graphing and statistical analyses. Graphs show means and standard errors. One-or two-way analysis of variance was used when means of more than two independent groups were subject to comparison across one or more time points, respectively. Statistical significance was defined as p-values < 0.05. Student's t-tests were used when there was one variable with two groups (Figure 1 ).

The authors declare no conflict of interest. 

IgE and mast cells in allergic disease

The mast cell and allergic diseases: Role in pathogenesis and implications for therapy

Mast Cell Responses to Viruses and Pathogen Products

Mast cells: Versatile regulators of inflammation, tissue remodeling, host defense and homeostasis

New and emerging roles for mast cells in host defence

Formalin sensitivity and differential staining of mast cells in human dermis

The mast cell: An antenna of the microenvironment that directs the immune response

A single dose of a vesicular stomatitis virus-based influenza vaccine confers rapid protection against H5 viruses from different clades

Mast Cell Biology at Molecular Level: A Comprehensive Review

Mast cell secretory granules: Armed for battle

Role of mast cell leukotrienes in neutrophil recruitment and bacterial clearance in infectious peritonitis

Inflammatory responses and inflammation-associated diseases in organs

The mast cell tumor necrosis factor alpha response to FimH-expressing Escherichia coli is mediated by the glycosylphosphatidylinositol-anchored molecule CD48

Fungal zymosan induces leukotriene production by human mast cells through a dectin-1-dependent mechanism

Protective Roles of Mast Cells Against Enterobacterial Infection Are Mediated by Toll-Like Receptor

Toll-Like Receptor-Mediated Activation of Mast Cells: Implications for Allergic Disease?

Altered function of murine mast cells in response to lipopolysaccharide and peptidoglycan

Bulfone-Paus, S. TLR3-induced activation of mast cells modulates CD8+ T-cell recruitment

FcepsilonR1 and toll-like receptors mediate synergistic signals to markedly augment production of inflammatory cytokines in murine mast cells

Mast cell progenitors: Origin, development and migration to tissues

Toll-like receptor 4-mediated activation of murine mast cells

Inflammatory Response of Mast Cells during Influenza A Virus Infection Is Mediated by Active Infection and RIG-I Signaling

RNA Sensors Enable Human Mast Cell Anti-Viral Chemokine Production and IFN-Mediated Protection in Response to Antibody-Enhanced Dengue Virus Infection

Immune surveillance by mast cells during dengue infection promotes natural killer (NK) and NKT-cell recruitment and viral clearance

Expression and Functional Characterization of Retinoic Acid-Inducible Gene-I-Like Receptors of Mast Cells in Response to Viral Infection

Mast Cell Cytokine and Chemokine Responses to Bacterial and Viral Infection

IL-6 production by rat peritoneal mast cells is not necessarily preceded by histamine release and can be induced by bacterial lipopolysaccharide

Prostanoid enhancement of interleukin-6 production by rat peritoneal mast cells

Cholera toxin increases IL-6 synthesis and decreases TNF-alpha production by rat peritoneal mast cells

Rat peritoneal mast cells produce IFN-gamma following IL-12 treatment but not in response to IgE-mediated activation

Interferon α2 and interferon γ induce the degranulation independent production of VEGF-A and IL-1 receptor antagonist and other mediators from human mast cells

Interferon-gamma promotes the survival and Fc epsilon RI-mediated histamine release in cultured human mast cells

Mast Cells Play a Key Role in Host Defense against Herpes Simplex Virus Infection through TNF-α and IL-6

Activation of mast cells by double-stranded RNA: Evidence for activation through Toll-like receptor

Respiratory syncytial virus infection of primary human mast cells induces the selective production of type I interferons, CXCL10, and CCL4

Human mast cell activation with virus-associated stimuli leads to the selective chemotaxis of natural killer cells by a CXCL8-dependent mechanism

Virus-Infected Human Mast Cells Enhance Natural Killer Cell Functions

A handpiece-mounted electronic axial alignment indicator

Infection of in vivo differentiated human mast cells with hantaviruses

Intracellular RNA recognition pathway activates strong anti-viral response in human mast cells

What came first, the virus or the egg: Innate immunity during viral coinfections

Skin Mast Cells Protect Mice against Vaccinia Virus by Triggering Mast Cell Receptor S1PR2 and Releasing Antimicrobial Peptides

Protective and pathogenic roles for mast cells during viral infections

Mast cells contribute to coronavirusinduced inflammation: New anti-inflammatory strategy

The pro-and anti-inflammatory properties of the cytokine interleukin-6

Limited replication of influenza A virus in human mast cells

Apoptosis and Pro-inflammatory Cytokine Response of Mast Cells Induced by Influenza A Viruses

LPS-induced production of TNF-α and IL-6 in mast cells is dependent on p38 but independent of TTP

Lipopolysaccharide-mediated mast cell activation induces IFN-gamma secretion by NK cells

Roles of retinoic acid-inducible gene-I-like receptors (RLRs), Toll-like receptor (TLR) 3 and 2 -5 oligoadenylate synthetase as viral recognition receptors on human mast cells in response to viral infection

Mast Cells in Inflammation and Disease: Recent Progress and Ongoing Concerns

IFNα enhances the production of IL-6 by human neutrophils activated via TLR8

VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents

Going viral with cancer immunotherapy

Synergistic Interaction Between Oncolytic Viruses Augments Tumor Killing

Dramatic caspase-dependent apoptosis in antibody-enhanced dengue virus infection of human mast cells

Altered mast cell activity in response to rhinovirus infection provides novel insight into asthma

Dengue Virus Selectively Induces Human Mast Cell Chemokine Production

Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: A promising inhibitory strategy

Endothelial Cells Are Central Orchestrators of Cytokine Amplification during Influenza Virus Infection

Recombinant Vesicular Stomatitis Virus Transduction of Dendritic Cells Enhances Their Ability to Prime Innate and Adaptive Antitumor Immunity

Dual effects of acetylsalicylic acid on mast cell degranulation, expression of cyclooxygenase-2 and release of pro-inflammatory cytokines

Stem cell factor and Interleukin-4 induce murine bone marrow cells to develop into mast cells with connective tissue type characteristics in vitro

Generation of Mast Cells from Mouse Fetus: Analysis of Differentiation and Functionality, and Transcriptome Profiling Using Next Generation Sequencer

Functional Expression of Neurokinin 1 Receptors on Mast Cells Induced by IL-4 and Stem Cell Factor

The authors thank University of Guelph Campus Animal Facilities for animal care services.